Persistent Atrial Fibrillation can sometimes stop on its own, but in many cases, it requires treatment to control the heart rhythm. For some individuals, it can be a lifelong condition that needs ongoing management.
Volt Atrial Fibrillation Clinical Trials in Oklahoma City, OK
Participating in Volt Atrial Fibrillation Clinical Trials in Oklahoma City, OK and help pave the way for new, life-saving treatments.
Enroll Now
Do You Have Persistent Atrial Fibrillation?
You might qualify for atrial fibrillation research.
Persistent Atrial Fibrillation affects millions of individuals and can significantly increase the risk of stroke and other complications. Despite advancements in medical technology, the need for safer, more effective treatments remains.
At Hightower, we’re conducting Volt AFIB Clinical Trials to evaluate the safety and effectiveness of the Volt™ Pulsed Field Ablation (PFA) system, a novel approach for treating symptomatic, recurrent, drug-resistant Persistent Atrial Fibrillation.
Participation in the Clinical Trial is free of cost and voluntary.
Fill out the form, and a member of our research team will contact you to determine your eligibility for the study.
About the Volt™ Pulsed Field Ablation (PFA) Study
Hightower is conducting a clinical trial to evaluate the safety and effectiveness of the Volt Pulsed Field Ablation system. This investigational system is designed to treat individuals with symptomatic, recurrent, drug-resistant Persistent Atrial Fibrillation (AFib).
This pre-market, multicenter study will assess whether the Volt™ PFA system—which includes the Volt™ PFA Catheter Sensor Enabled™, Volt™ PFA Generator, Agilis™ NxT Steerable Introducer Dual-Reach™, and EnSite™ X EP System—can provide effective, safe treatment for Persistent Atrial Fibrillation patients.
Participants will receive the Volt Pulsed Field Ablation treatment and be monitored closely to ensure safety and efficacy. This study aims to improve treatment outcomes for those affected by Persistent Atrial Fibrillation.
All procedures and treatments within the study are free of cost, and insurance is not required to participate.
The study doctor will guide you through every step of the clinical trial process, ensuring you have all the information you need before making a decision.
Atrial Fibrillation Research: What to Expect?
If you decide to participate in this clinical trial, you’ll first be asked to sign an Informed Consent Form that outlines all the key details of the study. Our dedicated research team will also walk you through the study process and explain your role. We encourage you to ask any questions before deciding to participate or withdraw from the study.
After signing the consent form and addressing any concerns, participants will be randomly assigned to one of two groups: the Control group or the Experimental group.
In the Control group, participants will receive a placebo with no active treatment, while the Experimental group will receive the investigational treatment. The study is double-blinded, meaning neither the researchers nor the participants will know which treatment is being administered.
All study-related care is provided at no cost. Experienced physicians and healthcare professionals will perform thorough assessments and physical exams throughout the study.
Age
18 Years and older (Adult, Older Adult)
Gender
Male & Female
Condition
Persistent Atrial Fibrillation
Current Status
Recruiting
What Happens in Persistent Atrial Fibrillation (AFib)?
Persistent Atrial Fibrillation (AFib) occurs when the heart’s electrical signals become disorganized, leading to an irregular and often rapid heart rhythm. This disrupts the normal blood flow through the heart, increasing the risk of blood clots, stroke, heart failure, and other heart-related complications.
Complications:
- Stroke: Persistent Atrial Fibrillation can cause blood to pool in the heart, forming clots. If a clot travels to the brain, it can cause a stroke.
- Heart Failure: The heart’s inefficiency in pumping blood can lead to weakened heart muscles, causing heart failure.
- Blood Clots: Irregular heartbeats increase the risk of blood clots, which can cause blockages in the arteries.
Symptoms:
- Irregular Heartbeat: You may feel your heart racing, fluttering, or skipping beats.
- Shortness of Breath: This may occur during activity or even while at rest.
- Fatigue: You may feel extremely tired or lacking in energy.
- Chest Pain: Some patients experience discomfort, pressure, or pain in the chest.
- Dizziness or Lightheadedness: AFib can cause episodes of dizziness or fainting due to inadequate blood flow.
- Weakness: Many individuals with AFib feel a general sense of weakness or low stamina.
Monitoring and managing Persistent Atrial Fibrillation Symptoms with the right treatment plan is essential to avoid severe complications.
Frequently Asked Questions
What Triggers an Episode of Persistent Atrial Fibrillation?
Common triggers for AFib include stress, caffeine, alcohol, certain medications, dehydration, or sleep deprivation. It’s important to identify and avoid your specific triggers.
How Is Persistent Atrial Fibrillation Diagnosed?
AFib is typically diagnosed through an electrocardiogram (ECG or EKG), a simple test that measures the electrical activity of the heart. Sometimes, additional tests like a Holter monitor or echocardiogram are needed for a more thorough evaluation.
Unlock New Opportunities in Clinical Research - Join Today!
We're here and eager to assist. Reach out to Hightower Clinical Research in Oklahoma City, OK for further details on how we can support you.
Get Involved Today!
© Copyright 2024 – Hightower Clinical. CREATED BY DIGITAL AUXILIUS.